# Attovia Therapeutics

**Canonical:** https://apis.io/providers/attovia/  
**Website:** https://www.attovia.com/  
**APIs profiled:** 0

Attovia Therapeutics is a clinical-stage biopharmaceutical company in San Carlos, California, founded in 2022 and developing next-generation precision biologics for immune-mediated diseases. Its proprietary ATTOBODY platform is a modular protein design technology built on biparatopic nanobody scaffolds, used to engineer multispecific biologics that inhibit two, three, or four disease-driving pathways from a single molecule while targeting improved selectivity, stability, and less frequent dosing than existing therapies. The lead program ATTO-1310 is an anti-IL-31 candidate in Phase 1 for chronic pruritus and high-itch atopic dermatitis; ATTO-2306 (IL-31 x IL-13) and ATTO-1091 (TL1A x IL-23p19 x integrin alpha-4-beta-7, for inflammatory bowel disease) are in IND-enabling studies, alongside discovery-stage programs in rheumatology, IBD, and respiratory disease. The company raised a $105M Series B led by Goldman Sachs Alternatives and listed on Nasdaq as ATTO in August 2026, raising $289M. Attovia publishes no public API, developer portal, SDK, or machine-readable specification — its product is therapeutics, not software.

## Kin Score — 11.8 / 100 (minimal)

Scored 2026-08-17 under rubric 0.11.0. Trend: flat (+0.0 from 11.8).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.3 |
| Commercial Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Attovia Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Biopharmaceutical, Life Sciences, Immunology, Therapeutics, Drug Discovery, Clinical Stage

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/attovia/). Scores are computed from the provider's own public artifacts under a published rubric.